MORIGI, ALICE
 Distribuzione geografica
Continente #
EU - Europa 1.263
NA - Nord America 1.239
AS - Asia 1.216
AF - Africa 85
SA - Sud America 57
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.865
Nazione #
US - Stati Uniti d'America 1.218
IT - Italia 431
SG - Singapore 355
VN - Vietnam 312
CN - Cina 283
SE - Svezia 187
DE - Germania 180
HK - Hong Kong 118
GB - Regno Unito 109
RU - Federazione Russa 69
NL - Olanda 63
IN - India 52
FR - Francia 47
BR - Brasile 42
IE - Irlanda 40
UA - Ucraina 35
TG - Togo 28
FI - Finlandia 24
JO - Giordania 24
KR - Corea 23
CI - Costa d'Avorio 22
NG - Nigeria 16
CA - Canada 15
BE - Belgio 13
ID - Indonesia 12
ZA - Sudafrica 12
AR - Argentina 11
ES - Italia 11
JP - Giappone 11
AT - Austria 10
PL - Polonia 10
TR - Turchia 9
BG - Bulgaria 6
EE - Estonia 6
SC - Seychelles 6
MX - Messico 5
AU - Australia 4
RO - Romania 4
RS - Serbia 4
DK - Danimarca 3
LT - Lituania 3
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
MK - Macedonia 2
MY - Malesia 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 3.865
Città #
Singapore 250
Ashburn 174
Chandler 141
Hong Kong 116
Santa Clara 115
Fairfield 95
Dong Ket 93
Southend 87
Bologna 66
Milan 52
Hefei 45
Beijing 44
Ho Chi Minh City 44
Princeton 44
Rome 42
Houston 41
Dublin 40
Seattle 37
Boardman 34
Falkenstein 30
Kyiv 30
Berlin 29
Lomé 28
Hanoi 27
Los Angeles 27
Wilmington 27
Woodbridge 26
Amman 24
Cambridge 23
New York 23
Seoul 23
Abidjan 22
Ann Arbor 22
Helsinki 18
Bremen 16
Abeokuta 15
Redmond 13
Secaucus 13
Brussels 12
Düsseldorf 11
Turin 11
Buffalo 10
Catania 10
Nanjing 10
Westminster 10
Columbus 9
Frankfurt am Main 9
Jinan 9
Shenyang 9
Tokyo 9
Da Nang 8
Jakarta 8
Olalla 8
Toronto 8
Warsaw 8
Dallas 7
Des Moines 7
Guangzhou 7
Istanbul 7
San Diego 7
São Paulo 7
Zhengzhou 7
Bengaluru 6
Chicago 6
Florence 6
Lappeenranta 6
Modena 6
Nuremberg 6
Verona 6
Vienna 6
Haiphong 5
Hyderabad 5
Jiaxing 5
London 5
Ottawa 5
Padova 5
Parma 5
Redwood City 5
Reggio Emilia 5
Saint Petersburg 5
Belgrade 4
Brooklyn 4
Changsha 4
Cinisello Balsamo 4
Ha Long 4
Murmansk 4
Nova Milanese 4
Nuoro 4
Quận Một 4
Redondo Beach 4
Stockholm 4
Thái Nguyên 4
Yubileyny 4
Adelaide 3
Aversa 3
Bergamo 3
Bắc Giang 3
Desio 3
Fuzhou 3
Genoa 3
Totale 2.375
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 437
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience 379
Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling 203
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 201
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study 188
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 177
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients 171
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 163
PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series 162
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 151
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies 151
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma 143
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma 141
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients 128
Granulomatous tattoo reaction in a nivolumab-treated patient 126
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 126
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma 123
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience 112
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience 106
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma 100
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series 97
Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience 92
Spontaneous remission of follicular lymphoma 87
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation 71
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 69
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report 58
Totale 3.962
Categoria #
all - tutte 11.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 6 5 15 40 9 16 149
2021/2022480 81 11 16 43 30 18 3 36 13 57 106 66
2022/2023645 46 100 49 85 54 43 14 61 99 16 40 38
2023/2024277 19 40 27 35 27 29 12 19 9 26 10 24
2024/20251.126 69 104 83 74 169 80 104 54 27 108 52 202
2025/2026806 159 194 114 131 163 45 0 0 0 0 0 0
Totale 3.962